Your browser doesn't support javascript.
loading
Heat shock protein 90: biological functions, diseases, and therapeutic targets.
Wei, Huiyun; Zhang, Yingying; Jia, Yilin; Chen, Xunan; Niu, Tengda; Chatterjee, Aniruddha; He, Pengxing; Hou, Guiqin.
Affiliation
  • Wei H; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Zhang Y; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Jia Y; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Chen X; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Niu T; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Chatterjee A; Department of Pathology Dunedin School of Medicine University of Otago Dunedin New Zealand.
  • He P; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
  • Hou G; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
MedComm (2020) ; 5(2): e470, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38283176
ABSTRACT
Heat shock protein 90 (Hsp90) is a predominant member among Heat shock proteins (HSPs), playing a central role in cellular protection and maintenance by aiding in the folding, stabilization, and modification of diverse protein substrates. It collaborates with various co-chaperones to manage ATPase-driven conformational changes in its dimer during client protein processing. Hsp90 is critical in cellular function, supporting the proper operation of numerous proteins, many of which are linked to diseases such as cancer, Alzheimer's, neurodegenerative conditions, and infectious diseases. Recognizing the significance of these client proteins across diverse diseases, there is a growing interest in targeting Hsp90 and its co-chaperones for potential therapeutic strategies. This review described biological background of HSPs and the structural characteristics of HSP90. Additionally, it discusses the regulatory role of heat shock factor-1 (HSF-1) in modulating HSP90 and sheds light on the dynamic chaperone cycle of HSP90. Furthermore, the review discusses the specific contributions of HSP90 in various disease contexts, especially in cancer. It also summarizes HSP90 inhibitors for cancer treatment, offering a thoughtful analysis of their strengths and limitations. These advancements in research expand our understanding of HSP90 and open up new avenues for considering HSP90 as a promising target for therapeutic intervention in a range of diseases.
Key words